Frank Curzio's WALL STREET UNPLUGGED Podcast

Mark Lichtenfeld on Biotech, Income Investments and a 2016 Forecast

Welcome back to another episode of Wall Street Unplugged!

My guest this week is Marc Lichtenfeld, chief income strategist at the Oxford Club, editor of the Oxford Income Letter and host of Mark Lichtenfeld’s Oxford Club Radio podcast.

On this episode, Marc shares his best ideas on the upcoming JP Morgan Healthcare Conference that he’ll be attending next week.

Marc then breaks down the biotech industry – a sector of the market he’s been covering for over a decade. 

[app_audio src=”http://traffic.libsyn.com/sainvestorradio/WSU20EP20378.mp3″]

Marc talks about these early stage companies that have huge upside potential. As Mark say’s, “It’s important to keep your emotions in check and your positions sizes small when you’re investing in these startups.”

Switching gears Mark gives us his forecast for 2016. You won’t want to miss this.  

And finally he covers stocks that he looks at for generating safe income. He likes the big healthcare companies, especially big pharmaceuticals and he gives us one of his best new recommendations that almost no one else is looking at.

As always, thanks for listening and good investing.